TMCnet News
This Morning's Research Reports on Healthcare Information Services Stocks -- athenahealth, Evolent Health, HealthEquity, and TeladocNEW YORK, April 4, 2018 /PRNewswire/ --WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on ATHN, EVH, HQY, and TDOC which can be accessed for free by signing up to www.wallstequities.com/registration. WallStEquities.com takes a closer look at the recent performance of athenahealth Inc. (NASDAQ: ATHN), Evolent Health Inc. (NYSE: EVH), HealthEquity Inc. (NASDAQ: HQY), and Teladoc Inc. (NYSE: TDOC). Companies in the Healthcare Information Services space provide data, products, and services that range from hospitals and physician practices to pharmaceutical and biotech companies, to private individuals. All you have to do is sign up today for this free limited time offer by clicking the link below. www.wallstequities.com/registration athenahealth Watertown, Massachusetts headquartered athenahealth Inc.'s stock finished Tuesday's session 0.20% higher at $137.89 with a total trading volume of 309,477 shares. The Company's shares have advanced 3.65% in the previous three months and 22.36% over the past year. The stock is trading 0.17% above its 50-day moving average and 2.40% above its 200-day moving average. Additionally, shares of athenahealth, which together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems, have a Relative Strength Index (RSI) of 47.00. On April 02nd, 2018, athenahealth announced that it will hold a conference call for investors on April 27th, 2018, at 8:00 a.m. ET. During the conference call, management will review highlights from the Company's Q1 2018 results, which will be announced via press release after the close of market trading on April 26th, 2018. The live conference call and webcast may be accessed under the Investors section of the Company's website. Get the full research report on ATHN for free by clicking below at: www.wallstequities.com/registration/?symbol=ATHN Evolent Health On Tuesday, shares in Arlington, Virginia headquartered Evolent Health Inc. recorded a trading volume of 421,678 shares. The stock ended the session 2.90% higher at $14.20. The Company's shares have advanced 15.45% in the previous three months. The stock is trading 1.79% below its 50-day moving average. Moreover, shares of Evolent Health, which through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the US, have an RSI of 47.60. On March 20th, 2018, Evolent Health (EVH) announced that ten of its partners have been formally accepted to the Center for Medicare and Medicaid Services' Next Generation Accountable Care Organization (ACO) program for the 2018 performance year, including four provider partners that are new to the Company's network. EVH will support nearly one-fifth of all organizations accepted to the Next Generation ACO program across the US to manage cost and quality of care for Medicare beneficiaries. Download our actionable research report on EVH at: www.wallstequities.com/registration/?symbol=EVH HealthEquity Draper, Utah headquartered HealthEquity Inc.'s shares closed the day 3.34% higher at $62.41. The stock recorded a trading volume of 597,585 shares. The Company's shares have gained 12.76% in the last month, 33.75% over the previous three months, and 47.02% over the past year. The stock is trading 12.18% and 24.49% above its 50-day and 200-day moving averages, respectively. Additionally, shares of HealthEquity, which provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the US, have an RSI of 58.68. On March 20th, 2018, research firm Chardan Capital Markets reiterated its 'Buy' rating on the Company's stock with an increase of the target price from $62 a share to $77 a share. Register for your free report coverage on HQY at: www.wallstequities.com/registration/?symbol=HQY Teladoc Shares in Purchase, New York headquartered Teladoc Inc. finished 3.90% higher at $40.00. The stock recorded a trading volume of 616,456 shares. The Company's shares have advanced 14.78% in the previous three months and 60.00% over the past year. The stock is trading above its 50-day and 200-day moving averages by 3.76% and 15.68%, respectively. Furthermore, shares of Teladoc, which provides telehealth services worldwide, have an RSI of 47.30. On March 15th, 2018, research firm Deutsche Bank downgraded the Company's stock rating from 'Buy' to 'Hold', with a target price of $45 per share. Get the free research report on TDOC at: www.wallstequities.com/registration/?symbol=TDOC -- Wall St. Equities: Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. WSE has not been compensated; directly or indirectly; for producing or publishing this document. PRESS RELEASE PROCEDURES: The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way. NO WARRANTY WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. NOT AN OFFERING This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://wallstequities.com/legal-disclaimer/ CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number: +21-32-044-483 Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228 CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Wall St. Equities 
|
View original content: